๐Ÿ“ˆ LEMMING INVESTOR RESEARCH by ๐Ÿ“ˆSmall Company Champion
๐Ÿ“ˆ The Investor Edge by ๐Ÿ“ˆSmall Company Champion
Investor Podcast #19
6
0:00
-30:58

Investor Podcast #19

6

๐Ÿ“ˆ LEMMING INVESTOR RESEARCH by ๐Ÿ“ˆSmall Company Champion is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

By Elric Langton | 16 March 2025

In todayโ€™s podcast, I discuss the moron trolling SkinBiotherapeutics and me. I sent the following introduction to the editor of Beauty Independent. I do not expect a response from them; it is merely a nudge in the right direction for their editorial team, which I hopeโ€”indeed, expectโ€”will spark interest among their editorial team and the founders and CEOs who contributed to their article.


I read your article titled;

Stagnation Or Evolution?: The Fierce Debate Over Beautyโ€™s Sputtering Ingredient Innovation.

Rachel Brown

For all the hype over a supposed miracle ingredient in a new launch, beauty industry insiders believe ingredient...

The skincare and cosmetics market is poised for a significant transformation. This April, at the In-Cosmetics forum, Croda will unveil a groundbreaking innovation that challenges the notion of "ingredient innovation stagnation."

Enter SkinBiotix Lysateโ€”a scientifically validated breakthrough set to redefine the role of lysated bacteria as a skincare active. Developed by SkinBioTherapeutics PLC, a spinout from the University of Manchester, this innovation is the brainchild of Dr Catherine Oโ€™Neill and Professor Andrew McBain. With two years of exclusive access granted to select Sederma VIPs and a wider release to 500 clients in late 2024, anticipation is high.

Dr Damien Kelly, VP at Croda, hails it as a game-changer, paving the way for a new era in biotech-driven skincare. Far from stagnation, this is innovation in action, with SkinBiotix Lysate leading the charge.

I have written extensively about this long journey; it has taken five years to arrive at a point of commercialisation not previously seen in the cosmetic market. This will be more revolutionary than Matrixl. No more smoke and mirrors marketing; specific anti-ageing claims can now be made during marketing and advertising campaigns that were never before permitted.


Opinions

We offer no advice or solicit the purchase of shares in any companies we discuss. However, shares go up and down in value, making your financial situation risky.

The views and opinions contained within these editorials are for research purposes and are the opinions of the author(s). We aim to be as accurate as possible but stress you should also perform your research and never act solely on the contents of these editorials.

Discussion about this episode

User's avatar